The Government of India has proposed the Biopharma Shakti initiative to strengthen the country’s biopharmaceutical sector. It aims to promote research, innovation, and domestic manufacturing of biopharma products such as vaccines and biosimilars. The initiative focuses on reducing import dependence, improving global competitiveness, and supporting startups and industries. It will also enhance infrastructure, skill development, and collaboration between academia and industry. This move is important for achieving self-reliance in healthcare and strengthening India’s position in the global biotech industry.
The Government of India proposed the Biopharma Shakti initiative in 2026 to strengthen the biopharmaceutical sector. It focuses on improving domestic production of vaccines, biosimilars, and other biological products. The initiative aims to reduce dependence on imports and increase India’s global competitiveness in biotechnology.
Key stakeholders include the Ministry of Science & Technology, biotech industries, startups, and research institutions. The program promotes collaboration between academia and industry to enhance research and development. It also supports infrastructure development and skill training in the biotech field.
Biopharmaceuticals are medicines produced using living organisms. These include vaccines, monoclonal antibodies, and gene therapies. India already has a strong position in vaccine production, supplying many countries globally.
The initiative is in news because it supports healthcare security and economic growth. It aligns with major government programs like Atmanirbhar Bharat and Make in India.
In the past, schemes like Biotechnology Industry Research Assistance Council (BIRAC) supported innovation in biotech. Biopharma Shakti builds on such efforts with a larger focus on manufacturing and global expansion.
Future impact includes improved healthcare access, increased exports, job creation, and stronger pandemic preparedness.
1.Biopharma Shakti initiative mainly focuses on:
A) Agriculture development
B) Biopharmaceutical sector growth
C) Space research
D) Education reforms
Answer: B
2.Biosimilars are:
A) Chemical drugs
B) Identical vaccines
C) Similar versions of biologic drugs
D) Herbal medicines
Answer: C
3.Biopharma Shakti aims to reduce:
A) Export levels
B) Import dependence in healthcare
C) Employment rate
D) Industrial production
Answer: B
4.Which sector benefits most from this initiative?
A) Textile
B) Biotechnology
C) Mining
D) Tourism
Answer: B
5.Biopharmaceuticals are produced using:
A) Minerals
B) Machines
C) Living organisms
D) Metals
Answer: C
Q. What are biosimilars in the pharmaceutical sector?
Answer: Drugs similar to already approved biological medicines.
Q. Which organization supports biotech innovation in India?
Answer: BIRAC
Students often confuse biosimilars with generic drugs. Biosimilars are not identical, but highly similar to biologics.
Focus on biotech terms like biosimilars, vaccines, and government initiatives related to healthcare manufacturing.